Cargando…
Optimal utilisation of sulphonylureas in resource-constrained settings
ABSTRACT: Sulphonylureas (SUs) are oral anti-diabetic drugs (OADs) that were introduced more than 60 years ago. Clinicians are familiar with their use and they remain extensively used. However, the SU class is associated with adverse effects of weight gain and hypoglycaemia. In addition, their effec...
Autores principales: | Naidoo, Poobalan, Rambiritch, Virendra, Butkow, Neil, Saman, Selvarajah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026768/ https://www.ncbi.nlm.nih.gov/pubmed/24844554 http://dx.doi.org/10.5830/CVJA-2014-007 |
Ejemplares similares
-
Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study
por: Rambiritch, Virendra, et al.
Publicado: (2014) -
Effect of Sitagliptin and Metformin on Prediabetes Progression to Type 2 Diabetes - A Randomized, Double-Blind, Double-Arm, Multicenter Clinical Trial: Protocol for the Sitagliptin and Metformin in PreDiabetes (SiMePreD) Study
por: Naidoo, Poobalan, et al.
Publicado: (2016) -
Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects
por: Rambiritch, Virendra, et al.
Publicado: (2016) -
Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects
por: Rambiritch, Virendra, et al.
Publicado: (2016) -
Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis
por: Jacobson, Barry, et al.
Publicado: (2019)